10,000
Participants
Start Date
September 30, 2024
Primary Completion Date
December 31, 2035
Study Completion Date
December 31, 2035
Pharmacological treatment
"Pharmacological and non pharmacological treatments will be assessed and monitored during the retrospective and prospective phase, and will include:~* bronchodilators, inhaled steroids and their combinations~* mucolytics~* biologic therapies for COPD~* roflumilast~* pulmonary rehabilitation"
Pharmacological treatment
"All pharmacological and non pharmacological treatments for COPD will be assessed and monitored during the retrospective and prospective phase of the study, and will include:~* inhaled bronchodilators (long term beta-2 agonists and cholinergic antagonists), inhaled corticosteroids and their combinations~* mucolytics~* biologics for COPD (monoclonal antibodies)~* roflumilast~* chronic oral azythromicin~* pulmonary rehabilitation~* oxygen therapy~* non invasive/invasive ventilation"
Luigi Sacco University Hospital, Division of Department of Biomedical and Clinical Sciences, University of Milan, Milan
University of Genova
OTHER
University of Pavia
OTHER
Azienda Ospedaliera Universitaria Integrata Verona
OTHER
University Magna Graecia
OTHER
University of Rome Tor Vergata
OTHER
Università degli Studi di Sassari
OTHER
University of Palermo
OTHER
University of Turin, Italy
OTHER
University Hospital Verona, Italy
UNKNOWN
University Hospital of Ferrara
OTHER
University of Milan
OTHER